Antiepileptic drug response in temporal lobe epilepsy: A clinical and MRI morphometry study

Neurology

Volumn 75, Issue 19, 2010, Pages 1695-1701

  Bilevicius, E ^a   Yasuda, C L ^a   Silva, M S ^a   Guerreiro, C A M ^a   Lopes Cendes, I ^a   Cendes, F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; BRAIN MAPPING; CEREBELLUM; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; EPILEPTIC FOCUS; FEBRILE CONVULSION; FEMALE; FRONTAL LOBE; GRAY MATTER; GRAY MATTER ATROPHY; HIPPOCAMPAL ATROPHY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MESIAL TEMPORAL LOBE EPILEPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; ONSET AGE; PARIETAL LOBE; PRIORITY JOURNAL; REMITTING RELAPSING SEIZURE; SEIZURE; SUBICULUM; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE; VOXEL BASED MORPHOMETRY;

EID: 78650022535     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fc29dd     Document Type: Article

References (40)

1. Semah F, Lamy C, Demeret S. Hippocampal sclerosis and other hippocampal abnormalities in the early identification of candidates for epilepsy surgery. Arch Neurol 2002;59: 1042-1043.
2. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localization-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001;42:357-362.
3. Arzimanoglou A, Ryvlin P. Towards a clinically meaningful definition of drug-resistance. In: Kahane P, Berg A, Löscher W, Nordli D, Perucca E, eds. Progress in Epileptic Disorders, vol. 7: Drug-Resistant Epilepsies. Mountrouge, France: John Libbey Eurotext; 2008:1-6.
4. Perucca E. Pharmacoresistance in epilepsy: how should it be defined? CNS Drugs 1998;10:171-179.
5. Berg AT. Postsurgical treatment of epilepsy. Epilepsy Curr 2004;4:127-130.
6. Varoglu AO, Saygi S, Acemoglu H, Ciger A. Prognosis of patients with mesial temporal lobe epilepsy due to hippocampal sclerosis. Epilepsy Res 2009;85:206-211.
7. Sillanpaä M, Schmidt D. Early seizure frequency and etiology predict long-term medical outcome in childhoodonset epilepsy. Brain 2009;132:989-998.
8. Kim WJ, Park SC, Lee SJ, et al. The prognosis of seizures with medications in patients with MRI evidence for mesial temporal sclerosis. Epilepsia 1999;40:290-293.
9. Sander JWAS. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993;34:1007-1016.
10. Tobias E, Brodie AF, Brodie MJ. An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals. Seizure 1994;3:37-43.
11. Mattson RH, Cramer JA, Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology 1996;47:68-76.
12. Bonilha L, Rorden C, Halford JJ, et al. Asymmetrical extra-hippocampal grey matter loss related to hippocampal atrophy in patients with medial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2007;78:286-294. (Pubitemid 46579668)
13. Cendes F, Andermann F, Gloor P, et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures? Ann Neurol 2003;34: 795-801.
14. Bernasconi N, Duchesne S, Janke A, et al. Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. NeuroImage 2004;23: 717-723. (Pubitemid 39370622)
15. Bonilha L, Rorden C, Castellano G, et al. Voxel-based morphometry reveals gray matter network atrophy in refractory medial temporal lobe epilepsy. Arch Neurol 2004; 61:1379-1384.
16. Labate A, Cerasa A, Aguglia U, et al. Voxel-based morphometry of sporadic epileptic patients with mesiotemporal sclerosis. Epilepsia 2010;51:506-510.
17. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
18. Yasuda CL, Valise C, Saúde AV, et al. Dynamic changes in white and gray matter volume are associated with outcome of surgical treatment in temporal lobe epilepsy. Neuroimage 2010;49:71-79.
19. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200.
20. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
21. França MC Jr, D'Abreu A, Yasuda C, et al. A combined voxel-based morphometry and H-MRS study in patients with Friedreich's ataxia. J Neurol 2009;256:1114-1120.
22. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using false discovery rate. Neuroimage 2002;15:870-878.
23. Korotkov A, Radovanovic S, Ljubisavljevic M, et al. Comparison of brain activation after sustained non-fatiguing and fatiguing muscle contraction: a positron emission tomography study. Exp Brain Res 2005;163:65-74.
24. Brodie MJ. Response to drug therapy: winners and losers. Epilepsia 2005;46(suppl 10):31-32.
25. Sillanpaä M, Schmidt D. Natural history of treated childhood onset epilepsy: prospective, long term population based study. Brain 2006;129:617-624.
26. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007; 75:192-196.
27. Schmidt D, Löscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009;9:47-52.
28. Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr 2008;8:127-130.
29. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000;48:833-841.
30. Sillanpaä M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain 2008;131:938-944.
31. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;3:314-319.
32. Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006;67:2117-2118.
33. Kumlien E, Doss RC, Gates JR. Treatment outcome in patients with mesial temporal sclerosis. Seizure 2002;11: 413-417.
34. Wieser HG. ILAE: Commission on neurosurgery of epilepsy: ILAE Commission Report: Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004;45: 695-714.
35. Riederer F, Lanzenberger R, Kaya M, et al. Network atrophy in temporal lobe epilepsy: a voxel-based morphometry study. Neurology 2008;71:419-425.
36. Keller SS, Wilke M, Wieshmann UC, et al. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004;23:860-868.
37. Mueller SG, Laxer KD, Cashdollar N, et al. Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2006;47:900-907.
38. Campos BA, Yasuda CL, Castellano G, Bilevicius E, Li LM, Cendes F. Proton MRS may predict AED response in patients with TLE. Epilepsia 2010;51:783-788.
39. Van Paesschen W, Dupont P, Van Driel H, et al. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain 2003;126:1103-1111.
40. Bertashius KM. Propagation of human complex-partial seizures: a correlation analysis. Electroencephalogr Clin Neurophysiol 1991;78:333-340.